Heparan sulfate is required for bone morphogenetic protein-7 signaling

Biochemical and Biophysical Research Communications

Volumn 308, Issue 4, 2003, Pages 858-865

  Irie, Atsushi ^a   Habuchi, Hiroko ^b   Kimata, Koji ^b   Sanai, Yutaka ^a  

^a TOKYO METROPOLITAN INSTITUTE OF MEDICAL SCIENCE   (Japan)

^b AICHI MEDICAL UNIVERSITY   (Japan)

Author keywords

Bone morphogenetic protein; Glycosaminoglycan; Heparan sulfate; Proteoglycan

Indexed keywords

HEPARAN SULFATE; HEPARIN; OSTEOGENIC PROTEIN 1; SMAD PROTEIN;

ANIMAL CELL; ARTICLE; BONE DEVELOPMENT; CELL MEMBRANE; CELL SURFACE; CONTROLLED STUDY; EMBRYO DEVELOPMENT; MOLECULAR INTERACTION; MORPHOGENESIS; NONHUMAN; OSTEOBLAST; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; RAT; SIGNAL TRANSDUCTION; SULFATION;

EID: 0042661060     PISSN: 0006291X     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0006-291X(03)01500-6     Document Type: Article

References (42)

1. Kjellén L., Lindahl U. Proteoglycans: structures and interactions. Annu. Rev. Biochem. 60:1991;443-475.
2. Esko J.D., Lindahl U. Molecular diversity of heparan sulfate. J. Clin. Invest. 108:2001;169-173.
3. David G. Integral membrane heparan sulfate proteoglycans. FASEB J. 7:1993;1023-1030.
4. Nakato H., Kimata K. Heparan sulfate fine structure and specificity of proteoglycan functions. Biochim. Biophys. Acta. 1573:2002;312-318.
5. Haerry T.E., Heslip T.R., Marsh J.L., O'Connor M.B. Defects in glucuronate biosynthesis disrupt Wingless signaling in Drosophila. Development. 124:1997;3055-3064.
6. Lin X., Perrimon N. Dally cooperates with Drosophila Frizzled 2 to transduce Wingless signalling. Nature. 400:1999;281-284.
7. Bellaiche Y., The I., Perrimon N. Tout velu is a Drosophila homologue of the putative tumour suppressor EXT-1 and is needed for Hh diffusion. Nature. 394:1998;85-88.
8. Reddi A.H. Bone and cartilage differentiation. Curr. Opin. Genet. Dev. 4:1994;737-744.
9. Hogan B.L. Bone morphogenetic proteins: multifunctional regulators of vertebrate development. Genes Dev. 10:1996;1580-1594.
10. Sampath T.K., Coughlin J.E., Whetstone R.M., Banach D., Corbett C., Ridge R.J., Özkaynak E., Oppermann H., Rueger D.C. Bovine osteogenic protein is composed of dimers of OP-1 and BMP-2A, two members of the transforming growth factor-β superfamily. J. Biol. Chem. 265:1990;13198-13205.
11. Ohkawara B., Iemura S., ten Dijke P., Ueno N. Action range of BMP is defined by its N-terminal basic amino acid core. Curr. Biol. 12:2002;205-209.
12. Paine-Saunders S., Viviano B.L., Economides A.N., Saunders S. Heparan sulfate proteoglycans retain Noggin at the cell surface: a potential mechanism for shaping bone morphogenetic protein gradients. J. Biol. Chem. 277:2002;2089-2096.
13. Jackson S.M., Nakato H., Sugiura M., Jannuzi A., Oakes R., Kaluza V., Golden C., Selleck S.B. dally, a Drosophila glypican, controls cellular responses to the TGF-β-related morphogen, Dpp. Development. 124:1997;4113-4120.
14. Paine-Saunders S., Viviano B.L., Zupicich J., Skarnes W.C., Saunders S. glypican-3 controls cellular responses to Bmp4 in limb patterning and skeletal development. Dev. Biol. 225:2000;179-187.
15. Grisaru S., Cano-Gauci D., Tee J., Filmus J., Rosenblum N.D. Glypican-3 modulates BMP- and FGF-mediated effects during renal branching morphogenesis. Dev. Biol. 231:2001;31-46.
16. Katagiri T., Yamaguchi A., Ikeda T., Yoshiki S., Wozney J.M., Rosen V., Wang E.A., Tanaka H., Omura S., Suda T. The non-osteogenic mouse pluripotent cell line, C3H10T1/2, is induced to differentiate into osteoblastic cells by recombinant human bone morphogenetic protein-2. Biochem. Biophys. Res. Commun. 172:1990;295-299.
17. Sampath T.K., Maliakal J.C., Hauschka P.V., Jones W.K., Sasak H., Tucker R.F., White K.H., Coughlin J.E., Tucker M.M., Pang R.H., Corbett C., Özkaynak E., Oppermann H., Rueger D.C. Recombinant human osteogenic protein-1 (hOP-1) induces new bone formation in vivo with a specific activity comparable with natural bovine osteogenic protein and stimulates osteoblast proliferation and differentiation in vitro. J. Biol. Chem. 267:1992;20352-20362.
18. Turnbull J., Powell A., Guimond S. Heparan sulfate: decoding a dynamic multifunctional cell regulator. Trends Cell Biol. 11:2001;75-82.
19. Heldin C.H., Miyazono K., ten Dijke P. TGF-β signalling from cell membrane to nucleus through SMAD proteins. Nature. 390:1997;465-471.
20. Tamaki K., Souchelnytskyi S., Itoh S., Nakao A., Sampath K., Heldin C.H., ten Dijke P. Intracellular signaling of osteogenic protein-1 through Smad5 activation. J. Cell. Physiol. 177:1998;355-363.
21. Greve H., Cully Z., Blumberg P., Kresse H. Influence of chlorate on proteoglycan biosynthesis by cultured human fibroblasts. J. Biol. Chem. 263:1988;12886-12892.
22. Humphries D.E., Silbert J.E. Chlorate: a reversible inhibitor of proteoglycan sulfation. Biochem. Biophys. Res. Commun. 154:1988;365-371.
23. David G., Bai X.M., Van der Schueren B., Cassiman J.J., Van den Berghe H. Developmental changes in heparan sulfate expression: in situ detection with mAbs. J. Cell Biol. 119:1992;961-975.
24. ten Dijke P., Yamashita H., Sampath T.K., Reddi A.H., Estevez M., Riddle D.L., Ichijo H., Heldin C.H., Miyazono K. Identification of type I receptors for osteogenic protein-1 and bone morphogenetic protein-4. J. Biol. Chem. 269:1994;16985-16988.
25. Rosenzweig B.L., Imamura T., Okadome T., Cox G.N., Yamashita H., ten Dijke P., Heldin C.H., Miyazono K. Cloning and characterization of a human type II receptor for bone morphogenetic proteins. Proc. Natl. Acad. Sci. USA. 92:1995;7632-7636.
26. Yamashita H., ten Dijke P., Huylebroeck D., Sampath T.K., Andries M., Smith J.C., Heldin C.H., Miyazono K. Osteogenic protein-1 binds to activin type II receptors and induces certain activin-like effects. J. Cell Biol. 130:1995;217-226.
27. Maliakal J.C., Asahina I., Hauschka P.V., Sampath T.K. Osteogenic protein-1 (BMP-7) inhibits cell proliferation and stimulates the expression of markers characteristic of osteoblast phenotype in rat osteosarcoma (17/2.8) cells. Growth Factors. 11:1994;227-234.
28. Kitten A.M., Lee J.C., Olson M.S. Osteogenic protein-1 enhances phenotypic expression in ROS 17/2.8 cells. Am. J. Physiol. 269:1995;E918-E926.
29. Gallagher J.T. Heparan sulfate: growth control with a restricted sequence menu. J. Clin. Invest. 108:2001;357-361.
30. Griffith D.L., Keck P.C., Sampath T.K., Rueger D.C., Carlson W.D. Three-dimensional structure of recombinant human osteogenic protein 1: structural paradigm for the transforming growth factor β superfamily. Proc. Natl. Acad. Sci. USA. 93:1996;878-883.
31. Scheufler C., Sebald W., Hülsmeyer M. Crystal structure of human bone morphogenetic protein-2 at 2.7 Å resolution. J. Mol. Biol. 287:1999;103-115.
32. Bullock S.L., Fletcher J.M., Beddington R.S., Wilson V.A. Renal agenesis in mice homozygous for a gene trap mutation in the gene encoding heparan sulfate 2-sulfotransferase. Genes Dev. 12:1998;1894-1906.
33. Luo G., Hofmann C., Bronckers A.L., Sohocki M., Bradley A., Karsenty G. BMP-7 is an inducer of nephrogenesis, and is also required for eye development and skeletal patterning. Genes Dev. 9:1995;2808-2820.
34. Barnett M.W., Fisher C.E., Perona-Wright G., Davies J.A. Signalling by glial cell line-derived neurotrophic factor (GDNF) requires heparan sulphate glycosaminoglycan. J. Cell Sci. 115:2002;4495-4503.
35. Naka D., Ishii T., Shimomura T., Hishida T., Hara H. Heparin modulates the receptor-binding and mitogenic activity of hepatocyte growth factor on hepatocytes. Exp. Cell Res. 209:1993;317-324.
36. Irie A., Yates E.A., Turnbull J.E., Holt C.E. Specific heparan sulfate structures involved in retinal axon targeting. Development. 129:2002;61-70.
37. Kasahara K., Sanai Y. Functional roles of glycosphingolipids in signal transduction via lipid rafts. Glycoconj. J. 17:2000;153-162.
38. Zajchowski L.D., Robbins S.M. Lipid rafts and little caves. Compartmentalized signalling in membrane microdomains. Eur. J. Biochem. 269:2002;737-752.
39. Tkachenko E., Simons M. Clustering induces redistribution of syndecan-4 core protein into raft membrane domains. J. Biol. Chem. 277:2002;19946-19951.
40. Kirsch T., Sebald W., Dreyer M.K. Crystal structure of the BMP-2-BRIA ectodomain complex. Nat. Struct. Biol. 7:2000;492-496.
41. Fujise M., Takeo S., Kamimura K., Matsuo T., Aigaki T., Izumi S., Nakato H. Dally regulates Dpp morphogen gradient formation in the Drosophila wing. Development. 130:2003;1515-1522.
42. Ruppert R., Hoffmann E., Sebald W. Human bone morphogenetic protein 2 contains a heparin-binding site which modifies its biological activity. Eur. J. Biochem. 237:1996;295-302.